MedTrace Logo

Efficacy and Safety Study of Kinerase® for Treatment of Cutaneous Facial Photodamage

NCT01885091 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2013-06-25

No results posted yet for this study

Summary

The purpose of the K.I.S.S. study is to evaluate the efficacy of Kinerase® Cream (Kinetin 0.1%) in Thai patients, on the basis of the severity and clinical signs of facial photodamage.

Conditions

  • Skin Roughness
  • Mottling
  • Blotchiness
  • Pigmentation
  • Fine Wrinkles

Interventions

OTHER

Kinerase

Sponsors & Collaborators

  • Menarini (Thailand) Limited

    lead INDUSTRY

Principal Investigators

  • Rungsima Wanitphakdeedecha, MD, MA, MSc · iSKY Innovative Skin & Laser Surgery Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-03-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01885091 on ClinicalTrials.gov